- জেনেরিক নাম
- Pirfenidone
- শক্তি
- 267 mg
- ডোজ ফর্ম
- Capsule
- প্রস্তুতকারক
- Opsonin Pharma Limited
৳ ৪৪.১ ৳ ৪৫ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
Pulbo 267 mg হলো Pirfenidone-এর একটি ব্র্যান্ড, শক্তি ২৬৭ mg, ক্যাপসুল আকারে। Pulbo 267 mg-এর প্রতি ইউনিটের দাম ৪৫ টাকা। Pulbo 267 mg-এর সাথে Pirfenidone-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এটি তৈরি করে Opsonin Pharma Limited। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Pirfenidone-এর ৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Pulbo 267 mg এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি।
The capsule Pulbo 267 mg contains Pirfenidone and is made by Opsonin Pharma Limited. Pirfenidone works on processes involved in scar tissue formation in the lungs. Do not begin, change or stop it on your own; the doctor decides the dose and course that suit you. Use it only as your doctor directs.
If you are unsure whether this medicine is right for you, speak with your doctor, who will assess your condition and decide on the appropriate treatment. IPF is a condition where lung tissue becomes scarred over time. Only a specialist physician experienced in diagnosing and treating IPF should start and supervise this treatment.
Pulbo 267 mg is taken by mouth. Swallow the capsule whole with water. Do not crush or chew the capsule. If you miss a dose, ask your doctor or pharmacist what to do. Do not change the dose or stop early without asking your doctor.
Like all medicines, Pulbo 267 mg can cause side effects. Some people may have other effects. Serious side effects were reported at similar rates to placebo in studies, but you should still report any unusual symptoms. Your doctor will explain what to watch for and when to call, since individual reactions vary and some effects need checking. Tell your doctor if any side effect bothers you or does not go away.
Liver function tests (ALT, AST and bilirubin) should be conducted prior to the initiation of treatment with Pirfenidone, and subsequently at monthly intervals for the firs As a precautionary measure, it is preferable to avoid the use of Pirfenidone during pregnancy. Rarely these have been associated with concomitant elevations in total serum bilirubin. Keep out of reach of children.
If you are unsure whether this medicine is right for you, speak with your doctor, who will assess your condition and decide on the appropriate treatment. IPF is a condition where lung tissue becomes scarred over time.
Pulbo 267 mg is taken by mouth. Swallow the capsule whole with water.
Like all medicines, Pulbo 267 mg can cause side effects. Some people may have other effects.
Liver function tests (ALT, AST and bilirubin) should be conducted prior to the initiation of treatment with Pirfenidone, and subsequently at monthly intervals for the firs As a precautionary measure, it is preferable to avoid the use of Pirfenidone during pregnancy. Rarely these have been associated with concomitant elevations in total serum bilirubin.
৳ ৪৪.১ ৳ ৪৫ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pirfenidone is indicated in adults for the treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pirfenidone is an orally active, small molecule that shows a wide range of biologic activity. In vitro evidence has shown that pirfenidone inhibits collagen synthesis, down-regulates profibrotic cytokines and decreases fibroblast proliferation. Pirfenidone leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase furin. In addition, pirfenidone reduces the protein levels of the matrix metalloproteinase (MMP)-11, a TGF-beta target gene and furin substrate involved in carcinogenesis.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Treatment with Pirfenidone should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of IPF. Upon initiating treatment, the dose should be titrated to the recommended daily dose of nine 267 mg tablets or one 801 mg tablet per day over a 14-days period for adult as follows:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity to the active substance or to any of the excipients, concomitant use of fluvoxamine, severe hepatic impairment or end stage liver disease, severe renal impairment (CrCl <30 ml/min) or end stage renal disease requiring dialysis.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The safety of Pirfenidone has been evaluated in clinical studies including 1345 healthy volunteers and patients. The most commonly reported (10%) adverse reactions during clinical study experience with Pirfenidone at a dose of 2403 mg/day compared to placebo, respectively, were nausea (32.8% versus 13.3%), rash (28.7% versus 8.6%), fatigue (22.3% versus 13.3%), diarrhoea (21.7% versus 13.5%), dyspepsia (16.8% versus 5.5%), and photosensitivity reaction (12.2% versus 1.7%). Serious adverse reactions were recorded at similar frequencies among patients treated with 2403 mg/day of Pirfenidone and placebo in clinical studies. The adverse reactions reported at a frequency of 2% in 345 patients receiving Pirfenidone at the recommended dose of 2403 mg/day in two pivotal Phase 3 studies. Adverse reactions from post-marketing experience are also listed. Adverse reactions are listed by System Organ Class (SOC) and within each frequency grouping the adverse reactions are presented in order of decreasing seriousness.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy: There are no data from the use of Pirfenidone in pregnant women. In animals placental transfer of pirfenidone and/or its metabolites occurs with the potential for accumulation of pirfenidone and/or its metabolites in amniotic fluid. At high doses (1000 mg/kg/day) rats exhibited prolongation of gestation and reduction in fetal viability. As a precautionary measure, it is preferable to avoid the use of Pirfenidone during pregnancy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is limited clinical experience with overdose. Multiple doses of pirfenidone up to a dose of 4806 mg/day were administered as six 267 mg capsules three times daily to healthy adult volunteers over a 12-day dose escalation period. Adverse reactions were mild, transient, and consistent with the most frequently reported adverse reactions for pirfenidone.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool and dry place, protected from light.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।